We only have this paper's title and publication details.
Read it at the sourceRetrospective analysis identifies gene fusions as potential prognostic biomarkers in advanced melanoma, suggesting implications for immune checkpoint blockade therapy.
Dysregulated pathways.
No takes yet. Share an insight, caveat, or question.
Nibeyro et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: